Background: Macular edema is the common sight-threatening condition following branch retinal vein occlusion. Objective: To fi nd spectral domain optical coherence tomography characteristics of macular involvement and visual acuity in the patients with branch retinal vein occlusion Methodology: This is a cross-sectional study; consecutive new cases of branch retinal vein occlusion diagnosed at the ophthalmology department of Kathmandu Medical College, Kathmandu were carried out from November 2016 to October 2017. All subjects were divided three groups with normotensive/controlled hypertension, stage 1 hypertension (systolic pressure >140mm Hg or diastolic pressure >90mm Hg) and Stage 2 hypertension (systolic pressure >160mm Hg or diastolic pressure >100mm Hg).The macular edema was evaluated by taking best corrected visual acuity and spectral domain optical coherence tomography for measurement of central foveal thickness. Results: Forty patients with forty eyes were enrolled. Mean age was 58.5 years SD ± 9.98 years. Stage 1 and stage 2 hypertensive groups had signifi cantly worse best corrected visual acuity and more thickness of central foveal thickness than normotensive/controlled group (p<0.001). The best corrected visual acuity and central foveal thickness were successively worse among normotensive group, stage 1 hypertensive group and stage 2 hypertensive group ( between normotensive/controlled group and stage 1 hypertensive group, p = 0.032 and 0.002 respectively and between stage I hypertensive group and stage 2 hypertensive group, p= 0.013 and 0.09 respectively). Conclusion: Control of hypertension could be a main contributing measure to lower incidence of branch retinal vein occlusion and the severity of macular edema.
INTRODUCTION

M
acular edema is the common sight-threatening condition following branch retinal vein occlusion (BRVO). About 5-30% of eyes with BRVO develop macular edema 1, 2 . Vitreous hemorrhage develops in about 40% of eyes with BRVO over an unspecifi ed time period and in 10% of eyes with central retinal vein occlusion (CRVO) within nine months of presentation 3 .
Hypertension is one of the important risk factors for BRVO and causes thickening of arteriole walls so BRVO occurs at sites where retinal arterio-venous crossing occurs. The obstruction in venous outfl ow after BRVO increases intra luminal venous pressure and causes transudation of plasma and blood, resulting in macular edema and retinal edema and hemorrhages. Edema increases interstitial pressure and further compromises arterial perfusion resulting in variable amounts of capillary non-perfusion and cotton wool spots. Extensive non-perfusion is associated with ischemic BRVO and results in poor visual prognosis.
This study focused on spectral domain optical coherence tomography (SD OCT) characteristics of macular involvement and visual acuity in the patients.
METHODOLOGY
The study was a hospital-based cross-sectional study. The subjects included in the study were those presenting to the Ophthalmology department of Kathmandu Medical College Teaching Hospital from November 2016 to October 2017. All consecutive new cases of BRVO diagnosed at the Institute with informed consent were included. Patients with diabetic mellitus, smoker, renal disease, severe dyslipidemia, intraocular infl ammation or a prior history of intraocular injections, laser therapy or vitrectomy for BRVO and the patients who refused to enroll in the study were excluded from the study. Arterial blood pressure was recorded in both arms in seated position by aneroid sphygmomanometer. All subjects were divided three groups with normotensive/ prehypertensive/ controlled hypertension (defi ned as systolic pressure <140mm Hg or diastolic pressure <90mm Hg), stage 1 hypertension (defi ned as systolic pressure >140mm Hg or diastolic pressure >90mm Hg) and Stage 2 hypertension (defi ned as systolic pressure >160mm Hg or diastolic pressure >100mm Hg) 4 . Snellen visual acuity (VA) was converted to log of the minimum angle of resolution (logMAR) for statistical analysis. The macular edema was evaluated by taking best corrected visual acuity, performing direct and indirect ophthalmoscopy with 90D and 20D and the patients were sent tertiary hospital for SD OCT (Ziess, cirrus) scan to measurement of central foveal thickness (CFT).
Ethical clearance was obtained from the Institutional Review Committee of Kathmandu Medical College, Sinamangal, Kathmandu. An informed written consent was taken from all enrolled patients. Data were entered and analyzed using statistical package for the social sciences (SPSS) version 20.0. Kruskal Wallis Test was applied for p value and a p-value of <0.05 was considered statistically signifi cant. Pearson's correlation of coeffi cient was applied.
RESULTS
The mean age of the patients was 58.5 years SD ± 9.98 years (range: 42-80). Females were preponderant (72.5%). Mean time of presentation was 16 days SD ±12.9 days. Seventy percent of patients gave no history of hypertension and remaining 30% gave history of hypertension under medication. Fifty percent (20) patients were having stage 2 followed by 25% (10) stage 1and 25% (10) were having normotensive/controlled. Superior temporal BRVO was predominant (83%). Stage 1 and stage 2 hypertensive groups had signifi cantly worse Best corrected visual acuity (BCVA) and more thickness of Central foveal thickness (CFT) than normotensive group (p<0.001) ( Table 1 ). In fi gure 5, a fi fty seven years female had systolic pressure 110 mmHg and diastolic 70 mmHg presented with left eye superiotemporal branch retinal vein occlusion. Her best corrected visual acuity was 6/6 and central foveal thickness was 235 µm showing spongy macular edema in SDOCT and in fi gure 6,a forty fi ve years male had systolic pressure 170 mmHg and diastolic 100 mmHg presented with left eye infero temporal branch retinal vein occlusion. His best corrected visual acuity BCVA was 1/60 and central foveal thickness was 621µm showing severe macular edema with subretinal fl uid in SDOCT. 
DISCUSSION
Branch Retinal vein occlusion is the common form of retinal vascular disease with prevalence rate of 0.5-2.0% 5, 6 . Mean age of BRVO patients was 58.5 years SD ± 9.98 years (minimum age 42 and maximum age 80) and our study was similar to the Beijing eye study 2 Fifty percentage (20) patients were having stage 2 hypertension followed by 25% (10) stage 1 hypertension and 25% (10) were having normotension/controlled. The data of published studies suggest that 48% of RVO is connected to hypertension, 20% to hyperlipidemia, and 5% to diabetes mellitus 8 . Systemic diseases such as hypertension, hyperlipidemia, and diabetes mellitus are very strongly associated with the development of RVO 9 . The study conducted in Korea shows that participants with uncontrolled hypertension had signifi cantly more RVO than participants without hypertension 10 . Zhou JQ et al found that signifi cantly higher levels of systolic and diastolic blood pressure were noted in retinal vein occlusion patients 8 . A hospital-based case-control study conducted in Nepal also shows a hypertension as a risk factor for RVO 11 . Findings from the study of Korean patients confi rm the strong association of hypertension with BRVO 12 .
The severity of hypertension had some correlation among worsening of BCVA and macular edema. In this study the BCVA and CFT were successively worse among normotensive/controlled hypertension group, stage 1 hypertensive group and stage 2 hypertensive group. Macular edema was found in 30% of BRVO eyes 2 . A case series shows the blood pressure of patients was closely associated with macular edema in RVO patients and if systemic hypertension is present, it should be treated before any anti-VEGF therapy was begun 13 .
Female were preponderant (75%) because the study excluded smokers who were mostly males. The prevalence of RVO was similar between men and women in all studies that reported the prevalence by gender 3 .
CONCLUSION
Macular edema and visual acuity of BRVO are successively worsened with severity of hypertension. So, early detection and control of hypertension could be a main contributing measure to lower the spectrum of BRVO.
LIMITATIONS
Further study should be done in large sample size to solidify the role of hypertension control in BRVO patients.
